Effect of polymorphisms in CYP3A4, PPARA, NR1I2, NFKB1, ABCG2 and SLCO1B1 on the pharmacokinetics of lovastatin in healthy Chinese volunteers
Pharmacogenomics January 2017, Vol. 18, No. 1, Pages 65-75.
Source: Future Medicine: Pharmacogenomics - Category: Genetics & Stem Cells Authors: Guilian Zhao Mei Liu Xiujun Wu Guofei Li Feng Qiu Jingkai Gu Limei Zhao Source Type: research
More News: Lovastatin